182 related articles for article (PubMed ID: 34605572)
1. Inhibition of MAD2B alleviates venous neointimal formation by suppressing VSMCs proliferation and migration.
Song AN; Yin XJ; Gao P; Tang H; Meng XF; Zhang C
FASEB J; 2021 Nov; 35(11):e21959. PubMed ID: 34605572
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PIKfyve Ameliorates the Proliferation and Migration of Vascular Smooth Muscle Cells and Vascular Intima Hyperplasia By Reducing mTORC1 Activity.
Gu M; Wang Z; Feng F; Yang Y; Sun X; Yang D
J Cardiovasc Pharmacol; 2022 May; 79(5):739-748. PubMed ID: 35275098
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima.
Hwang AR; Lee HJ; Kim S; Park SH; Woo CH
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175802
[TBL] [Abstract][Full Text] [Related]
4. Shexiang Baoxin Pill Regulates Intimal Hyperplasia, Migration, and Apoptosis after Platelet-Derived Growth Factor-BB-Stimulation of Vascular Smooth Muscle Cells via miR-451.
Li YP; Qiang TT; Wang KY; Wang XL
Chin J Integr Med; 2022 Sep; 28(9):785-793. PubMed ID: 35840853
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.
Wu JH; Li Y; Zhou YF; Haslam J; Elvis ON; Mao L; Xia YP; Hu B
Cardiovasc Res; 2017 Dec; 113(14):1763-1775. PubMed ID: 29016743
[TBL] [Abstract][Full Text] [Related]
6. Omentin reduces venous neointimal hyperplasia in arteriovenous fistula through hypoxia-inducible factor-1 alpha inhibition.
Zhui L; Yuling C; Hansheng W; Xiangjie L
Microvasc Res; 2024 Jul; 154():104688. PubMed ID: 38640999
[TBL] [Abstract][Full Text] [Related]
7. OCT4 regulated neointimal formation in injured mouse arteries by matrix metalloproteinase 2-mediated smooth muscle cells proliferation and migration.
Ding X; Yan Y; Zhang C; Xu X; Yang F; Liu Y; Wang G; Qin Y
J Cell Physiol; 2021 Jul; 236(7):5421-5431. PubMed ID: 33372301
[TBL] [Abstract][Full Text] [Related]
8. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
9. Dual Function for Mature Vascular Smooth Muscle Cells During Arteriovenous Fistula Remodeling.
Zhao J; Jourd'heuil FL; Xue M; Conti D; Lopez-Soler RI; Ginnan R; Asif A; Singer HA; Jourd'heuil D; Long X
J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360226
[TBL] [Abstract][Full Text] [Related]
10. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
11. Rosmarinic Acid Inhibits Platelet Aggregation and Neointimal Hyperplasia In Vivo and Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration In Vitro via Activation of the Keap1-Nrf2-ARE Antioxidant System.
Chen C; Ma J; Xu Z; Chen L; Sun B; Shi Y; Miao Y; Wu T; Qin M; Zhang Y; Zhang M; Cao X
J Agric Food Chem; 2022 Jun; 70(24):7420-7440. PubMed ID: 35687823
[TBL] [Abstract][Full Text] [Related]
12. Role of Nuclear Receptor Subfamily 1 Group D Member 1 in the Proliferation, Migration of Vascular Smooth Muscle Cell, and Vascular Intimal Hyperplasia.
Wang M; Qiu C; Pan Q; Yang Y; Yang D; Sun X
J Cardiovasc Pharmacol; 2023 Sep; 82(3):221-228. PubMed ID: 37381169
[TBL] [Abstract][Full Text] [Related]
13. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia.
Wang Z; Gan X; Qiu C; Yang D; Sun X; Zeng Z
Toxicol Appl Pharmacol; 2019 Nov; 383():114747. PubMed ID: 31499192
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation.
Zhu N; Xiang Y; Zhao X; Cai C; Chen H; Jiang W; Wang Y; Zeng C
J Cell Mol Med; 2019 Dec; 23(12):8482-8492. PubMed ID: 31638340
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VRK1 suppresses proliferation and migration of vascular smooth muscle cells and intima hyperplasia after injury via mTORC1/β-catenin axis.
Sun X; Zhao W; Wang Q; Zhao J; Yang D; Yang Y
BMB Rep; 2022 May; 55(5):244-249. PubMed ID: 35410639
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury.
Kwon MY; Liu X; Lee SJ; Kang YH; Choi AM; Lee KU; Perrella MA; Chung SW
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2441-7. PubMed ID: 21903945
[TBL] [Abstract][Full Text] [Related]
17. Activation of CD137 signaling promotes neointimal formation by attenuating TET2 and transferrring from endothelial cell-derived exosomes to vascular smooth muscle cells.
Li B; Zang G; Zhong W; Chen R; Zhang Y; Yang P; Yan J
Biomed Pharmacother; 2020 Jan; 121():109593. PubMed ID: 31766102
[TBL] [Abstract][Full Text] [Related]
18. Coptisine inhibits neointimal hyperplasia through attenuating Pak1/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization.
Chen Y; Jiang X; Yuan Y; Chen Y; Wei S; Yu Y; Zhou Q; Yu Y; Wang J; Liu H; Hua X; Yang Z; Chen Z; Li Y; Wang Q; Chen J; Wang Y
Atherosclerosis; 2024 Apr; 391():117480. PubMed ID: 38447436
[TBL] [Abstract][Full Text] [Related]
19. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.
Feng S; Gao L; Zhang D; Tian X; Kong L; Shi H; Wu L; Huang Z; Du B; Liang C; Zhang Y; Yao R
Int J Biol Sci; 2019; 15(12):2615-2626. PubMed ID: 31754334
[No Abstract] [Full Text] [Related]
20. A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
Serrano RL; Yu W; Graham RM; Bryan RL; Terkeltaub R
PLoS One; 2019; 14(4):e0212235. PubMed ID: 30943188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
